厄贝沙坦联合海昆肾喜胶囊治疗老年糖尿病肾病的效果  

The Effect of Irbesartan Combined with Haikun Shenxi Capsules in the Treatment of Elderly Diabetic Nephropathy

作　　者：张玉坤 ZHANG Yukun(Department of Nephrology,Jinqiu Hospital of Liaoning Province,Shenyang 110016,China)

机构地区：[1]辽宁省金秋医院肾内科,辽宁沈阳110016

出　　处：《中国医学创新》2025年第7期36-39,共4页Medical Innovation of China

摘　　要：目的:评价老年糖尿病肾病(DN)患者使用厄贝沙坦联合海昆肾喜胶囊的临床效果及血糖水平改善效果。方法:选择2021年12月—2023年6月辽宁省金秋医院肾内科诊疗的80例老年DN患者,按随机数字表法将其分为对照组与研究组,各40例。对照组予以厄贝沙坦治疗,研究组在对照组基础上联合海昆肾喜胶囊治疗。对比两组血糖水平、血管内皮功能参数、临床症状评分、肾功能指标。结果:相比对照组,研究组治疗后血糖水平、血管内皮功能参数、临床症状评分、肾功能指标均更低,差异均有统计学意义(P<0.05)。结论:厄贝沙坦联合海昆肾喜胶囊治疗老年DN临床效果显著,可有效降低患者血糖水平,改善血管内皮功能,缓解临床症状,并保护肾功能。Objective:To evaluate the clinical effect and improvement of blood glucose level of Irbesartan combined with Haikun Shenxi Capsules in elderly patients with diabetic nephropathy(DN).Method:Eighty elderly DN patients treated in the Nephrology Department of Jinqiu Hospital of Liaoning Province from December 2021 to June 2023 were selected and divided into a control group and a study group according to random number table method,with 40 cases in each group.The control group was treated with Irbesartan,while the study group was treated with Haikun Shenxi Capsules combined with Irbesartan.The blood glucose level,vascular endothelial function parameters,clinical symptom scores,and renal function indicators were compared between the two groups.Result:Compared with the control group,the study group had lower blood glucose levels,vascular endothelial function parameters,clinical symptom scores,and renal function indicators after treatment,with statistically significant differences(P<0.05).Conclusion:The clinical effect of combining Irbesartan with Haikun Shenxi Capsules in the treatment of elderly DN is significant,which can effectively reduce blood glucose levels,improve vascular endothelial function,alleviate clinical symptoms,and protect renal function.

关 键 词：海昆肾喜胶囊 厄贝沙坦 糖尿病肾病 血糖水平 血管内皮功能 

分 类 号：R587.2[医药卫生—内分泌] R692[医药卫生—内科学]